Searchable abstracts of presentations at key conferences in endocrinology

ea0035p600 | Endocrine tumours and neoplasia | ECE2014

Cushing’s syndrome caused by ectopic corticotrophin secretion

Przybylik-Mazurek Elwira , Kuzniarz-Rymarz Sylwia , Pach Dorota , Sowa-Staszczak Anna , Gilis-Januszewska Aleksandra , Hubalewska-Dydejczyk Alicja

Cushing’s syndrome caused by ectopic ACTH secretion (EAS) constitutes ~10% of Cushing’s syndrome (CS).The aim of this study was to present experience of our Clinic with EAS.).Patients: Twelve patients, aged 14–70 years: four females and eight males.Outcomes and measurements: Clinical features, medical examination, morning electrolytes, glucose level, serum cortisol, ACTH levels, midnight plasma...

ea0035p741 | Obesity | ECE2014

Effects of depressive symptoms on clinical outcomes, inflammatory markers and quality of life after a significant weight loss in a bariatric surgery sample

Frances Carla , Nicolau Joana , Ayala Luisa , Julian Javier , Speranskaya Aleksandra , Zubillaga Ivana , Rivera Rosmeri , Fortuny Regina , Masmiquel Lluis

Background and aims: Obesity is linked to a low-grade and chronic systemic inflammation that improves after a significant weight loss. In the same way, depressive disorder has been suggested to be associated with systemic inflammation up regulation. We aimed to explore whether, after a significant weight loss, the presence of depressive symptoms was associated with differences in terms of inflammatory markers and quality of life compared with individuals without significant de...

ea0035p832 | Pituitary Basic (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Correlation of coexpression of pituitary genes in QPCR and microarray study in pituitary adenomas

Zebracka-Gala Jadwiga , Larysz Dawid , Pfeifer Aleksandra , Rudnik Adam , Krajewska Jolanta , Hasse-Lazar Kornelia , Kowalska Malgorzata , Bazowski Piotr , Jarzab Barbara

Introduction: Mechanism of pathogenesis of pituitary adenomas is still unknown. Gene expression differences in pituitary cells of different origin are not extensively described. Identification of genes specific for pituitary adenomas should enable better understanding of differences in their response to therapy, especially to radiotherapy.Aim: The aim of our study was to evaluate the correlation of coexpression of distinct pituitary adenoma genes based o...

ea0035p1015 | Thyroid (non-cancer) | ECE2014

Differences in genetic predisposition to Graves' disease and Graves' orbitopathy between young and elderly patients

Jurecka-Lubieniecka Beata , Ploski Rafal , Kula Dorota , Stechly Tomasz , Krol Aleksandra , Bednarczuk Tomasz , Tukiendorf Andrzej , Kolosza Zofia , Jarzab Barbara

Background: Graves’ disease (GD) is a complex disease in which genetic predisposition is modified by environmental factors. The pathogenesis of GD and Graves’ orbitopathy (GO) might have a different genetic background – in some patients GO is observed before or late after diagnosis of GD hyperthyroidism. The aim of the study was to assess genetic predisposition to GD and GO in young patients (age of diagnosis ≤30 years of age), in which the time of environ...

ea0070aep692 | Pituitary and Neuroendocrinology | ECE2020

Quantitative bone assessment by radiofrequency echographic multi-spectrometry (REMS) in patients with acromegaly – a preliminary study

Halupczok-Żyła Jowita , Rolla Małgorzata , Jawiarczyk-Przybyłowska Aleksandra , Kolackov Katarzyna , Bolanowski Marek

Introduction: Acromegaly is a rare diseaseresulting most commonly from pituitary adenoma. A chronic increase of growth hormone (GH) and insulin-like factor 1 (IGF-1) leads to many systemic complications including osteoporosis and fractures. Radiofrequency echographic multi-spectrometry (REMS) is a new non-ionizing technique to diagnose osteoporosis.Purpose: The objective of the study was to evaluate bone mineral density (BMD) by REMS in patient...

ea0070aep735 | Pituitary and Neuroendocrinology | ECE2020

Metabolic status of patients with combined pituitary hormone deficiency due to PROP1 mutation

Rogoziński Damian , Gilis-Januszewska Aleksandra , Kluczyński Łukasz , Godlewska Magdalena , Hubalewska-Dydejczyk Alicja

Introduction: Combined pituitary hormone deficiency (CPHD) due to PROP1 mutation is a rare cause of childhood-onset pituitary disfunction. Treatment with growth hormone is crucial for the proper development during childhood and adolescence, and to maintain adequate metabolic processes in the adulthood. There are other factors influencing patients metabolism e.g. steroid and estradiol/testosterone treatment.Aim: To assess metabolic status of patients with...

ea0032p523 | Endocrine tumours and neoplasia | ECE2013

Six-years experience in the treatment of the neuroendocrine tumors with the use of peptide receptor radionuclide therapy (PRRT)

Sowa-Staszczak Anna , Stefanska Agnieszka , Tomaszuk Monika , Gilis-Januszewska Aleksandra , Pach Dorota , Mikolajczak Renata , Hubalewska-Dydejczyk Alicja

Introduction: The aim of this study was to assess the efficacy of peptide receptor radionuclide therapy (PRRT) with the use of 90Y-DOTATATE and the survival rate of patients with disseminated or non-operable neuroendocrine tumors (NETs).Methods: In the time period from June 2006 to October 2012, 70 patients were treated with PRRT in our department. The 90Y-DOTATATE therapeutic activity was calculated per total body surface area up t...

ea0032p748 | Obesity | ECE2013

Differences among clinical, analytical and psychological outcomes among patients with an eating disorder after bariatric surgery

Nicolau Joana , Ayala Luisa , Rivera Rosmeri , Speranskaya Aleksandra , Olivares Josefina , Gil Apolonia , Puga Maria , Fortuny Regina , Masmiquel Lluis

Introduction: Information regarding eating disorders (ED) in postsurgical outcomes after bariatric surgery (BS) is scarce.Objectives: To analyze the effect of BS on ED and to investigate if ED influence clinical, biochemical or psychological outcomes.Methods: Sixty patients (78.3%♀, age 46.35±9.89, months since BS 46.28±28.1) who underwent BS, with a minimum follow up of 12 months, were evaluated cross-sectionally. ...

ea0020p198 | Endocrine tumours and neoplasia | ECE2009

Gastric neuroendocrine tumors – new diagnostic and therapeutic approach

Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra , Sowa-Staszczak Anna , Pach Dorota , Trofimiuk Malgorzata , Tomaszczuk Monika , Kulig Jan

The incidence of gastric neuroendocrine tumors (GNT) is increasing, what can be explained by the increased detection caused by the common use of the endoscopy and the pervasive use of acid suppressive therapy leading to enterochromatofine like cells proliferation. There are numerous new diagnostic/therapeutic GNT methods in use like: EUS, SRS, somatostatin therapy and 90Y/177Lu-DOTA-TATE radiotherapy.Materials and methods: In 1998–2008 37 patients w...

ea0020p239 | Bone/Calcium | ECE2009

The results of cinacalcet therapy in patients with severe or refractory hypercalcemia due to primary hyperparathyroidism

Krajewska Jolanta , Paliczka-Cieslik Ewa , Krawczyk Aleksandra , Szpak-Ulczok Sylwia , Michalik Barbara , Hasse-Lazar Kornelia , Jurecka-Lubieniecka Beata

Refractory or severe hypercalcemia is important clinical problem as it can lead to serious complications such as arrhythmias, acute or chronic pancreatitis, gastric ulcer, water and electrolyte balance disturbances, osteoporosis, psychoses and even to hypercalcemic crisis. Most often it is diagnosed in parathyroid cancer (PC). It is also observed in benign primary hyperparathyroidism (HPTH) in case of difficulties with adenoma’s localization. Routinely treatment includes ...